CardioTech International, Inc. Announces Its Participation In The Robins Emerging Opportunities Investment Conference
WILMINGTON, Mass., May 16 /PRNewswire-FirstCall/ -- CardioTech International, Inc. today announced that Eric G. Walters, CardioTech's Vice President and CFO, will be presenting at the Robins Emerging Opportunities Investment Conference being held at The University Club in New York City on May 17, 2006. Emerging opportunities companies that have been hand-selected by Marc Robins, CFA and his teams at The Robins Group and Catalyst Financial Resources will each have an opportunity to present their investment characteristics to small-cap institutional investors and financial media. For more information about the conference, please visit: http://www.catalystresearch.com.
About CardioTech International:
CardioTech International, Inc. is a medical device company that develops, manufactures and sells advanced products to surgically treat cardiovascular disease. CardioTech is currently developing new products that address annual worldwide markets exceeding $1 billion. CardioPass is CardioTech's proprietary, synthetic coronary artery bypass graft and CardioTech has partnered to develop a drug-eluting stent with CorNova.
CardioTech's corporate headquarters are located in Wilmington, Massachusetts, with operations in California and Minnesota. CardioTech generates revenues from sales of advanced medical devices and disposables used during cardiopulmonary bypass procedures, as well as from contracted product design and development services. More information about CardioTech, and the investor presentation, can be found at its website: http://www.cardiotech-inc.com.
About The Robins Group:
The Robins Group was created to provide professional investors with high quality research and brokerage services on under-followed small- and micro-cap equities. We prefer well-managed companies that dominate their particular niches through superior service, products and technology. Our research team employs fundamental analysis to arrive at a measure of value. Earnings power, cash flow, revenue growth, book value and financial strength are among the factors evaluated to determine investment potential. Accordingly, we aim to develop the kind of insightful money-making ideas, both growth and value oriented, the Street used to deliver prior to the 90's bubble.
About Catalyst Financial Resources:
Catalyst Financial Resources, LLC is an investor awareness firm helping small- and micro-cap companies gain credible exposure in the financial community. Employing the Catalyst System(TM), we augment a firm's existing investor relations activities and assist in achieving appropriate valuation in the marketplace. The Catalyst System(TM) was born out of an intense commitment to the small-cap, under-followed market and the need to forge a new standard on Wall Street. Founded in 2002 by Marc Robins, CFA, Catalyst Financial Resources has a proven track record of meeting the needs of both the management and the shareholders of small-cap companies.
Contact: CardioTech International Dr. Michael Szycher Eric G. Walters (978) 657-0075 The Robins Group Rick Owens (503) 445-2486 Catalyst Financial Resources Connie Schadewitz (360) 828-8601CardioTech International, Inc.
CONTACT: Dr. Michael Szycher or Eric G. Walters, both of CardioTechInternational, +1-978-657-0075; or Rick Owens of The Robins Group,+1-503-445-2486; Connie Schadewitz of Catalyst Financial Resources,+1-360-828-8601
Web site: http://www.cardiotech-inc.com//